| Trial name or title |
Prostate Cancer Patient‐centered Care (PCPCC): impact of a treatment decision aid in a pragmatic, cluster randomized controlled trial |
| Methods |
RCT |
| Participants |
Inclusion criteria
Men that are newly diagnosed with early stage prostate cancer Tumour stage T1 or T2 Maximum PSA‐score of 20 Maximum Gleason‐score of 7 Patients who are eligible for at least two treatment options Patients (in the intervention arm) have to be able to make use of a computer with internet‐access in order make use of the web‐based decision aid. Patients have to be able to read and understand Dutch language.
Exclusion criteria
Patients with advanced cancer If the urologist judges the patient is not in the right condition to participate In the case of a second opinion when the other involved hospital also uses a decision aid from this or an other study
|
| Interventions |
The control group will receive usual care; information provision and provided decisional support will be given according to the hospital standards. In addition to usual care, the intervention group will be granted access to an online decision aid, providing patients with structured information on the risks and benefits of the different treatment options and offer value‐clarification tasks. A summary is obtained to discuss with their physician during the following consultation. |
| Outcomes |
Primary outcomes
Secondary outcomes
Decision‐making role Knowledge about prostate cancer Satisfaction with information Preparation for decision making Health‐related quality of life Personality (anxiety, depression, optimism) and skills measures (self‐efficacy, health literacy, numeracy)
|
| Starting date |
May 2014 |
| Contact information |
M. Cuypers, +31 13 466 28 55, M.Cuypers@uvt.nl |
| Notes |
|
